SUNZEN BIOTECH |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.32 MYR | +1.59% |
|
-1.54% | +6.67% |
| Apr. 09 | Sunzen Biotech to End Operations of Loss-Making Animal Health Unit | MT |
| Feb. 29 | Sunzen Biotech Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2021 | 90.48M 18.99M | Sales 2022 | 97.09M 20.37M | Capitalization | 141M 29.57M |
|---|---|---|---|---|---|
| Net income 2021 | - 0 | Net income 2022 | 3M 630K | EV / Sales 2021 | 1.49 x |
| Net cash position 2021 | 41.96M 8.81M | Net cash position 2022 | 6.98M 1.47M | EV / Sales 2022 | 1.38 x |
| P/E ratio 2021 |
227
x | P/E ratio 2022 |
42.6
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 31.04% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.59% | ||
| 1 week | -1.54% | ||
| Current month | -3.03% | ||
| 1 month | +1.59% | ||
| 3 months | +10.34% | ||
| 6 months | +56.10% | ||
| Current year | +6.67% |
1 week
0.30
0.33
1 month
0.300.35
Current year
0.220.35
1 year
0.190.35
3 years
0.180.35
5 years
0.030.35
10 years
0.030.54
| Managers | Title | Age | Since |
|---|---|---|---|
Yek Ming Teo
CEO | Chief Executive Officer | 41 | 20-06-15 |
Tong Eng Phang
DFI | Director of Finance/CFO | 61 | 08-02-11 |
Weng Soon Cheng
SEC | Corporate Secretary | - | Nov. 28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yew Weng Lee
BRD | Director/Board Member | 47 | 20-07-31 |
Kien Hoe Khoo
BRD | Director/Board Member | 53 | 14-07-21 |
Yek Ming Teo
CEO | Chief Executive Officer | 41 | 20-06-15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 0.32 | +1.59% | 890,800 |
| 24-04-24 | 0.315 | +3.28% | 589,200 |
| 24-04-23 | 0.305 | 0.00% | 331,200 |
| 24-04-22 | 0.305 | -1.61% | 956,500 |
| 24-04-19 | 0.31 | -4.62% | 3,218,100 |
End-of-day quote BURSA MALAYSIA, April 24, 2024
More quotes
Sunzen Biotech Berhad is a Malaysia-based company, which is principally engaged in the businesses of biotechnology research and development, manufacturing and marketing of animal feed supplement products and investment holding. The Company operates through four segments: Manufacturing and trading of animal health products, Trading and processing of crude palm oil and related products, Traditional Chinese medicines and herbal health foods and beverages, and Loan financing. Its products include bird's nest, The Joy of Life collagen drink, Pu Yao Jing tonic, essence of chicken, essence of fish, Pi Pa Gao cough syrup, Bai Foong Wan, food supplements, dried herbs and more. The products are widely distributed to all consumers through retail concept stores in Malaysia as well in Ecolite store online shop. Its subsidiaries include Sunzen Corporation Sdn. Bhd., Sunzen International Sdn. Bhd., Finsource Credit (M) Sdn. Bhd., and Sunzen Lifesciences Sdn. Bhd among others.
Sector
Food Processing
Calendar
2024-05-23
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +6.67% | 47.24M | |
| -2.25% | 95.24B | |
| +3.76% | 46.64B | |
| -0.72% | 40.77B | |
| +9.58% | 40.3B | |
| +0.38% | 38.22B | |
| -15.54% | 30.61B | |
| -6.61% | 29.66B | |
| +13.14% | 25.09B | |
| -10.87% | 22.26B |
- Stock Market
- Equities
- SUNZEN Stock
